NFE2L2 and lung cancer: In contrast to the cytoprotective role of Nrf2 in normal cells, accumulating evidence suggests that persistently high activation of Nrf2 in various type of cancers, including lung cancer, is related with progression, metastasis, and resistance against chemotherapy and radiotherapy, which leads to poor prognosis16,19,20.